154 related articles for article (PubMed ID: 11483796)
1. Association between serum macrophage colony-stimulating factor levels and monocyte and thrombocyte counts in healthy, hypoxic, and septic term neonates.
Oren H; Duman N; Abacioglu H; Ozkan H; Irken G
Pediatrics; 2001 Aug; 108(2):329-32. PubMed ID: 11483796
[TBL] [Abstract][Full Text] [Related]
2. Increased macrophage-colony stimulating factor levels in neonates with perinatal complications.
Ikeno K; Koike K; Fukuromoto T; Shimizu T; Nagatomo M; Komiyama A
Early Hum Dev; 1996 Nov; 46(3):229-37. PubMed ID: 8922567
[TBL] [Abstract][Full Text] [Related]
3. In vivo effect of rhGM-CSF And rhG-CSF on monocyte HLA-DR expression of septic neonates.
Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Tzimouli V; Taparkou A; Kremenopoulos G; Germenis A
Cytokine; 2002 Jun; 18(5):260-5. PubMed ID: 12161101
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
[TBL] [Abstract][Full Text] [Related]
5. Circulating thrombopoietin levels in neonates with infection.
Colarizi P; Fiorucci P; Caradonna A; Ficuccilli F; Mancuso M; Papoff P
Acta Paediatr; 1999 Mar; 88(3):332-7. PubMed ID: 10229048
[TBL] [Abstract][Full Text] [Related]
6. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
[TBL] [Abstract][Full Text] [Related]
7. New insights into thrombopoiesis in neonatal sepsis.
Eissa DS; El-Farrash RA
Platelets; 2013; 24(2):122-8. PubMed ID: 22746320
[TBL] [Abstract][Full Text] [Related]
8. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor.
François B; Trimoreau F; Vignon P; Fixe P; Praloran V; Gastinne H
Am J Med; 1997 Aug; 103(2):114-20. PubMed ID: 9274894
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis.
Miura E; Procianoy RS; Bittar C; Miura CS; Miura MS; Mello C; Christensen RD
Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430
[TBL] [Abstract][Full Text] [Related]
10. Production and expression of granulocyte- and macrophage-colony-stimulating factors in newborns: their roles in leukocytosis at birth.
Ishii E; Masuyama T; Yamaguchi H; Saito S; Irie K; Nomiyama M; Motoyoshi K; Miyazaki S
Acta Haematol; 1995; 94(1):23-31. PubMed ID: 7544522
[TBL] [Abstract][Full Text] [Related]
11. Thrombocytopenia in late preterm and term neonates after perinatal asphyxia.
Christensen RD; Baer VL; Yaish HM
Transfusion; 2015 Jan; 55(1):187-96. PubMed ID: 25082082
[TBL] [Abstract][Full Text] [Related]
12. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
[TBL] [Abstract][Full Text] [Related]
13. High serum human macrophage colony-stimulating factor level during pregnancy.
Saito S; Motoyoshi K; Ichijo M; Saito M; Takaku F
Int J Hematol; 1992 Jun; 55(3):219-25. PubMed ID: 1498314
[TBL] [Abstract][Full Text] [Related]
14. G-CSF, GM-CSF and IL-6 levels in cord blood: diminished increase of G-CSF and IL-6 in preterms with perinatal infection compared to term neonates.
Weimann E; Rutkowski S; Reisbach G
J Perinat Med; 1998; 26(3):211-8. PubMed ID: 9773382
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer.
Cole DJ; Sanda MG; Yang JC; Schwartzentruber DJ; Weber J; Ettinghausen SE; Pockaj BA; Kim HI; Levin RD; Pogrebniak HW
J Natl Cancer Inst; 1994 Jan; 86(1):39-45. PubMed ID: 8271281
[TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation.
Carr R; Modi N; Doré CJ; El-Rifai R; Lindo D
Pediatrics; 1999 Apr; 103(4 Pt 1):796-802. PubMed ID: 10103305
[TBL] [Abstract][Full Text] [Related]
17. Macrophage colony-stimulating factor (M-CSF) prevents infectious death induced by chemotherapy in mice, while granulocyte-CSF does not.
Hidaka T; Fujimura M; Nakashima A; Higuma S; Yamagishi N; Tsuda H; Sakai M; Saito S
Jpn J Cancer Res; 2002 Apr; 93(4):426-35. PubMed ID: 11985793
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of granulocyte colony-stimulating factor in healthy term and preterm neonates and in those with various diseases including bacterial infections.
Gessler P; Kirchmann N; Kientsch-Engel R; Haas N; Lasch P; Kachel W
Blood; 1993 Nov; 82(10):3177-82. PubMed ID: 7693041
[TBL] [Abstract][Full Text] [Related]
19. In vivo effect of recombinant human granulocyte colony-stimulating factor on neutrophilic expression of CD11b in septic neonates: a randomized controlled trial.
El-Ganzoury MM; El-Farrash RA; Saad AA; Mohamed AG; El-Sherbini IG
Pediatr Hematol Oncol; 2012 Apr; 29(3):272-84. PubMed ID: 22475305
[TBL] [Abstract][Full Text] [Related]
20. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
Lehrnbecher T
Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
